Vaccination With Dendritic Cells Pulsed With Autologous Tumor Homogenate in Combination With HD-IL2 and Immunomodulating Radiotherapy in Metastatic RCC

NCT03226236 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped No patients enrolled due to change in standard practice

Conditions

Carcinoma, Renal Cell
Vaccination
Secondary

Interventions

RADIATION: boost radiotherapy (XRT)
BIOLOGICAL: Autologous DC vaccine
DRUG: High-Dose IL-2

Sponsor

Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS